Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > A Nanoscale Development With Macro Potential

Assistant professor Andrew MacKay.  
Photo/Kukla Vera
Assistant professor Andrew MacKay. Photo/Kukla Vera

Abstract:
The future of cancer treatment might be microscopic in size, at least according to USC School of Pharmacy assistant professor Andrew MacKay's groundbreaking research.

A Nanoscale Development With Macro Potential

Los Angeles, CA | Posted on December 9th, 2009

MacKay developed new strategies that, when executed on a nanoscale, have successfully led to tumor regression. The strategies involve the self-assembly of genetically engineered materials into nanoscale, drug-loaded packages.

MacKay and his team developed an artificial recombinant, chimeric polypeptide (CP) that spontaneously self-assembles into near-monodisperse, 40-nm-sized nanoparticles. His group demonstrated that this approach is a general and simple strategy to form drug-loaded nanomedicines from safe, biodegradable polypeptides.

These nanomedicines were used to deliver chemotherapeutics to mouse tumors and proved to be more effective than free drugs (an active drug that is not bound to a carrier protein). Not only did drug tolerance increase fourfold, but the use of these innovative chemotherapeutics led to nearly complete tumor regression after only a single dose. While the tumor used in the laboratory was associated with colon cancer in mice, this approach also could be used to treat a variety of cancers.

MacKay believes that packaging drugs into nanoscale delivery vehicles could be particularly useful for cancer therapy. Until now, mechanisms to assemble nanomedicines have relied on complex strategies using non-biocompatible materials.

To overcome this deficiency, MacKay and co-workers designed their drug carriers from a polypeptide sequence found in an elastic protein in human tissues. MacKay identified this approach as one of the necessary criteria to develop effective cancer drug treatments. The genetically engineered chimeric polypeptide molecules allow for this assembly and are novel for their generality, simplicity and biodegradability.

Although MacKay's developments are on a small scale, their impact has huge potential. His work with chimeric polypeptide and nanomedicines was featured in Nature Materials in November.

####

About University of Southern California
Located in Los Angeles, a global center for arts, technology and international trade, the University of Southern California is one of the world’s leading private research universities. USC enrolls more international students than any other U.S. university and offers extensive opportunities for internships and study abroad. With a strong tradition of integrating liberal and professional education, USC fosters a vibrant culture of public service and encourages students to cross academic as well as geographic boundaries in their pursuit of knowledge.

For more information, please click here

Contacts:

Copyright © University of Southern California

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Possible Futures

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

GLOBALFOUNDRIES Demonstrates Industry-Leading 112G Technology for Next-Generation Connectivity Solutions: High bandwidth, low power SerDes IP portfolio enables ‘connected intelligence’ in data centers and networking applications November 15th, 2017

Counterfeits and product piracy can be prevented by security features, such as printed 3-D microstructures: Forgeries and product piracy are detrimental to society and industry -- 3-D microstructures can increase security -- KIT researchers develop innovative fluorescent 3-D stru November 15th, 2017

Self Assembly

Physicists gain new insights into nanosystems with spherical confinement: Enormous potential for the targeted delivery of pharmaceutical agents and the creation of tailored nanoparticles July 27th, 2017

Oddball enzyme provides easy path to synthetic biomaterials May 17th, 2017

Nanotubes that build themselves April 14th, 2017

Nanocages for gold particles: what is happening inside? March 16th, 2017

Nanomedicine

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Announcements

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

Nanobiotechnology

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Age-old malaria treatment found to improve nanoparticle delivery to tumors: Nanomedicine researchers find new use for 70-year-old drug November 7th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project